fbpx
QQQ
+ 0.00
316.41
+ 0%
DIA
+ 0.00
309.31
+ 0%
SPY
+ 0.00
378.64
+ 0%
TLT
+ 0.00
152.31
+ 0%
GLD
+ 0.00
172.53
+ 0%

Tilray CEO Talks Global Cannabis Interest, New Participants In Bloomberg Interview

September 5, 2019 12:48 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Tilray CEO Talks Global Cannabis Interest, New Participants In Bloomberg Interview

Cannabis company Tilray, Inc. (NASDAQ:TLRY) participated in The Barclays Global Consumer Staples Conference, and CEO Brendan Kennedy told Bloomberg there is "a lot of interest" among participants in gaining new exposure to cannabis.

What Happened

Many Fortune 500 CPG brands are looking at the cannabis industry as an area for potential growth over the next decade, Kennedy said on "Bloomberg Daybreak: Americas" Thursday.

For the time being, many companies are taking a cautious approach toward exposing themselves to cannabis, and exploratory conversations take a full year before any progress is made, he said.

The cannabis sector remains in a very early stage, as medical cannabis is legalized in just 20% of the world, Kennedy said.

Legalization of recreational cannabis has taken place in just two countries, which accounts for 1% of the world, the CEO said.

Ultimately, medical and recreational legalization will expand globally and help usher in a $150-billion to $200-billion industry, he said.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Why It's Important

If the global cannabis market expands as Kennedy said it will, his company will be well-positioned to address the demand.

Tilray started 2018 with 60,000 square feet of manufacturing space, a figure that grew to 1.1 million square feet at the start of 2019.

Today, the company's footprint stands at 3.4 million square feet worldwide.

What's Next

Tilray's recent earnings report showed a notable uptick in exports but a decline in average selling price.

The company's ASP was impacted by the mix of products sold and should tick higher in the fourth quarter as Tilray starts selling new value-added products in Canada, Kennedy said. 

Tilray shares were up 5% at $31.50 at the time of publication Thursday.

Related Links:

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

New Report Puts North American Cannabis Market At $47.3B By 2024


Related Articles

Aphria CEO Talks Up Tilray Deal, Expects To Be EBIDTA-Positive And 'Not Burning Cash'

Earlier this month, cannabis growers Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) announced a merger to create the largest enterprise in the industry by revenue. read more

Stock Wars: Aurora Cannabis Vs. Tilray

Pot stocks have been trading higher on the heels of Joe Biden being announced as the 2020 presidential election winner. The five states that passed legalization for adult-use cannabis and medical cannabis also bolstered the market. Today, we take a look at two of the hottest pot stocks on major exchanges in the United States. read more

Cannabis Job Outlook In 2021 Is 'Strong' Despite Suffering Layoffs Throughout 2020

This year was a rollercoaster ride for the cannabis industry, which had its fair share of highs and lows. There were legalization breakthroughs, while various cannabis companies enforced massive layoffs. However, there were also those that did quite a bit of hiring. read more